Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/16/2015 01/20/2015 01/21/2015 01/22/2015 01/23/2015 Date
37.19(c) 37.78(c) 36.165(c) 36.25(c) 35.95(c) Last
1 447 261 2 762 156 1 286 687 554 459 165 536 Volume
+1.86% +1.59% -4.27% +0.24% -0.83% Change
More quotes
Company
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company.It focuses on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic... 
Sector
Pharmaceuticals
Calendar
01/27 | 08:30amShareholder meeting
More about the company
Surperformance© ratings of Auxilium Pharmaceuticals,
Trading Rating : - Investor Rating :
More Ratings
Chart AUXILIUM PHARMACEUTICALS,
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 398 M
EBIT 2014 14,7 M
Net income 2014 -163 M
Debt 2014 479 M
Yield 2014 -
Sales 2015 497 M
EBIT 2015 104 M
Net income 2015 71,5 M
Debt 2015 364 M
Yield 2015 -
PER 2014 -
PER 2015 25,68
EV / Sales 2014 5,81x
EV / Sales 2015 4,42x
Capitalization 1 834 M
More Financials
Latest news on AUXILIUM PHARMACEUTICALS,
01/21DJEndo International to Join S&P 500 as Boston Beer Moves Up to MidCap List
01/21 AUXILIUM PHARMACEUTICALS : Other Events (form 8-K)
01/16 AUXILIUM PHARMACEUTICALS : Other Events (form 8-K)
2014 AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
2014 AUXILIUM PHARMACEUTICALS : Sobi's Xiapex receives positive opinion by CHMP for t..
2014 AUXILIUM PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
2014 AUXILIUM PHARMACEUTICALS : Announces Date for Special Meeting of Stockholders
2014 AUXILIUM PHARMACEUTICALS : Other Events (form 8-K)
More news
Sector news Biopharmaceuticals
09:03aDJMARKET SNAPSHOT : Apple Earnings, Fed Vie For Investor Attention This Week
01/24DJNPS PHARMACEUTICALS : Correction to NPS Hormone Drug Article on Friday
01/24 German insurers win discounts on Gilead's Sovaldi
Plus d'actualités du secteur Biopharmaceuticals


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF